Home Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia
Article
Licensed
Unlicensed Requires Authentication

Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia

  • Anita Pfenniger , Christine Schuller , Patricia Christoph and Daniel Surbek EMAIL logo
Published/Copyright: April 2, 2012

Abstract

Objective: The purpose of this study is to compare the safety and efficacy of intravenous (IV) high-dose iron carboxymaltose (ICM) with iron sucrose (IS) for the treatment of postpartum anemia.

Study design: We performed a retrospective cohort study with 210 anemic inpatient women in the postpartum period who received IV high-dose ICM (15 mg/kg; maximum, 1000 mg) or IS (2×200 mg), respectively. Safety and tolerability of both groups were compared on the basis of reported systemic and local adverse events. The cohorts were matched for baseline characteristics and their initial hemoglobin (Hb) values. The secondary endpoint included drug efficacy assessment by measurement of Hb level increase up to 8 days after treatment.

Results: Rapid administration of high ICM doses was as well tolerated as IS with overall adverse events of 5% (ICM) vs. 6% (IS). The most common complaint was burning and pain at the injection site. ICM was as effective as IS in changing Hb levels from the baseline. There was no difference in the mean daily Hb increase between the groups. Women with severe anemia showed the most effective responsiveness.

Conclusions: IV ICM is as safe as IS in the management of postpartum (IDA) iron deficiency anemia despite five times of higher dosage. Both drugs are effective and offer a rapid normalization of Hb after delivery. The single application of ICM shows advantages of lower incidence of side effects at the injection site, a shorter treatment period, and better patient compliance.


Corresponding author: Prof. Daniel Surbek, MD Department of Obstetrics and Gynecology University Hospital Insel Effingerstrasse 102 CH-3010 Bern Switzerland Tel.: +41 31 632 11 03 Fax: +41 31 632 11 05

Received: 2011-9-22
Revised: 2012-2-5
Accepted: 2012-3-6
Published Online: 2012-04-02
Published in Print: 2012-06-01

©2012 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Review Article
  4. Noninvasive prenatal diagnosis of Down syndrome: current knowledge and novel insights
  5. Original Articles – Obstetrics
  6. Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm delivery
  7. An evolutionary test of the isoform switching hypothesis of functional progesterone withdrawal for parturition: humans have a weaker repressive effect of PR-A than mice
  8. Fetomaternal hemorrhage in the second trimester
  9. Contribution of 3D power Doppler ultrasound to the evaluation of placental circulation in normal pregnancies and pregnancies complicated by preeclampsia
  10. Two vs. three or more primary recurrent pregnancy losses – are there any differences in epidemiologic characteristics and index pregnancy outcome?
  11. Oxidative stress stimulates α-tocopherol transfer protein in human trophoblast tumor cells BeWo
  12. Risk factors for preeclampsia in twin pregnancies: a population-based matched case-control study
  13. Bishop score and cervical length at 33–35 weeks of gestation and the risk of intrapartum cesarean delivery of twins
  14. Primary vs. secondary recurrent pregnancy loss – epidemiological characteristics, etiology, and next pregnancy outcome
  15. Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia
  16. Knowledge gap of recommendations in ACOG practice bulletins: A survey of members of the Central Association of Obstetricians and Gynecologists
  17. Original Articles – Fetus
  18. Three years’ experience of using a 29-gauge atraumatic needle for amniocentesis
  19. Role of foetal MRI in the evaluation of ischaemic-haemorrhagic lesions of the foetal brain
  20. Original Articles – Newborn
  21. Acquisition of full enteral feeds may depend on stooling pattern in very premature infants
  22. An open-label, randomized efficacy and safety trial of subcutaneous and intramuscular BT088 (Fovepta) human hepatitis B immunoglobulin in neonates of HBV-carrier mothers
  23. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis
  24. Therapeutic hypothermia and hypoxic ischemic encephalopathy: opinion and practice of pediatricians in South Africa
  25. Circulating endothelial progenitor cells in premature infants: is there an association with premature birth complications?
  26. Short Communication
  27. The impact of length of second stage of labor on shoulder dystocia outcomes: a retrospective cohort study
  28. Congress Calender
  29. Congress Calendar
Downloaded on 5.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2011-0239/html
Scroll to top button